Ionis' ION582: Breakthrough Therapy for Angelman Syndrome

ION582, a new medicine for Angelman Syndrome, received FDA Breakthrough status! It aims to fix the root cause, showing early promise in improving communication, thinking, and movement for this severe neurological condition.